Eupraxia Pharmaceuticals Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -237.5% | -237.5% | -96.7% |
| FY2023 | -1,273.4% | -1,273.4% | -139.3% |
| FY2024 | -76.3% | -76.3% | -73.0% |
| FY2025 | -47.0% | -47.0% | -44.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -237.5% | -237.5% | -96.7% |
| FY2023 | -1,273.4% | -1,273.4% | -139.3% |
| FY2024 | -76.3% | -76.3% | -73.0% |
| FY2025 | -47.0% | -47.0% | -44.8% |